[ad_1]
Reuters DR / FW1F / Simon Newman / FW1 / Janet M
An image of the AstraZeneca vaccine
Pascal Soriot, CEO of Anglo-Swedish pharmaceutical company AstraZeneca, confirmed that his company’s vaccine was able to achieve a “successful equation” regarding efficacy against Corona.
Read more
In an interview with the “Sunday Times” newspaper, he said the “Oxford-AstraZeneca” vaccine, which is currently being evaluated by an independent UK medical products regulator, offers “100% protection” against acute cases. of “Covid-19” requiring hospitalization.
He expressed his belief that experiments will show that his institution has achieved a vaccine equal to the efficacy of “Pfizer-Biontech” by 95 percent and “Moderna” by 94.5 percent.
He added: “We believe we have deduced the successful equation and how to achieve efficacy after two doses,” noting that this data will be released at some point.
The first trials had shown mixed results for the “AstraZeneca” vaccine, initially the average rate of effectiveness was 70 percent, before climbing to 90 percent, depending on the dose.
High hopes have been placed on the “AstraZeneca” vaccine, which is based on a weak version of a virus taken from chimpanzees, due to its low cost.
The vaccine also has a logistical advantage, as it can be stored and transported under normal cooling conditions between 2 and 8 degrees Celsius for a period of at least six months, which is not comparable to the vaccine “Pfizer- Bionic “, which should be stored at 70 degrees.
Source: “AFP”
[ad_2]
Source link
